Literature DB >> 2162108

Transcriptional activity of the Rous sarcoma virus long terminal repeat correlates with binding of a factor to an upstream CCAAT box in vitro.

B T Greuel1, L Sealy, J E Majors.   

Abstract

The avian nuclear protein, enhancer factor 1 (EF1), binds specifically to the long terminal repeat (LTR) of Rous sarcoma virus (RSV) in a region that has been implicated in enhancer/promoter function. We have characterized the in vitro binding properties of this factor from chick embryo nuclear extracts by methylation interference/protection foot-printing of the wild-type LTR and also by gel electrophoretic mobility shift assays performed on a series of LTR mutants. We find that the inverted CCAAT pentanucleotide located at position -129 is essential for EF1 binding in vitro. Nucleotides flanking this element exert a smaller effect on binding. Linker-substitution and point mutations which reduce EF1 binding to this site in vitro also reduce promoter activity in transiently transfected cells. EF1 also binds with lower affinity to another inverted CCAAT box at position -65, an element which we show is also essential for transcriptional activity of the RSV LTR. We conclude, therefore, that EF1 is a CCAAT box-binding factor which is involved in the activation of RSV transcription in avian cells. Furthermore, we show that EF1 can recognize the CCAAT boxes of several other promoters in which the functional importance of this pentanucleotide has been established.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2162108     DOI: 10.1016/0042-6822(90)90457-3

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  CArG, CCAAT, and CCAAT-like protein binding sites in avian retrovirus long terminal repeat enhancers.

Authors:  K R Zachow; K F Conklin
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

2.  Characterization of the DNA-binding domain of the avian Y-box protein, chkYB-2, and mutational analysis of its single-strand binding motif in the Rous sarcoma virus enhancer.

Authors:  A Nambiar; S K Swamynathan; J C Kandala; R V Guntaka
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

3.  Chicken YB-2, a Y-box protein, is a potent activator of Rous sarcoma virus long terminal repeat-driven transcription in avian fibroblasts.

Authors:  S K Swamynathan; A Nambiar; R V Guntaka
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

4.  Functional and defective components of avian endogenous virus long terminal repeat enhancer sequences.

Authors:  D E Habel; K L Dohrer; K F Conklin
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

5.  Cloning and characterization of chicken YB-1: regulation of expression in the liver.

Authors:  C E Grant; R G Deeley
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

6.  Multiple forms of C/EBP beta bind the EFII enhancer sequence in the Rous sarcoma virus long terminal repeat.

Authors:  R C Sears; L Sealy
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

Review 7.  Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y?

Authors:  D Dolfini; R Mantovani
Journal:  Cell Death Differ       Date:  2013-03-01       Impact factor: 15.828

8.  Transcription factor binding and spacing constraints in the human beta-actin proximal promoter.

Authors:  S L Danilition; R M Frederickson; C Y Taylor; N G Miyamoto
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

9.  Identification of EFIV, a stable factor present in many avian cell types that transactivates sequences in the 5' portion of the Rous sarcoma virus long terminal repeat enhancer.

Authors:  E K Houtz; K F Conklin
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Mapping the transcriptional transactivation function of simian virus 40 large T antigen.

Authors:  J Y Zhu; P W Rice; M Chamberlain; C N Cole
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.